SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer

por Olukoya, Ayodeji O, Stires, Hillary, Guerra, Yanira, Persaud, Sonali, Ma, Shihong, Raj, Ganesh V, Riggins, Rebecca B
Publicado 2020

THU495 Glutamate Metabolic Enzymes GLUD1/2 And GPX4 Are Associated with Tumor Size In Black Women With Invasive Lobular Breast Cancer

por Young, Todd, Abalum, Theresa C, Hodgins, Nicole, Persaud, Sonali, Fernandez, Aileen I, Olukoya, Ayodeji Olajuwon, Rozeboom, Aaron Mark, Riggins, Rebecca Baab
Publicado 2023

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer

por Bahnassy, Shaymaa, Benitez, Carlos, Cruz, M Idalia, Guerra, Yanira, Ma, Shihong, Persaud, Sonali, Raj, Ganesh, Riggins, Rebecca, Stires, Hillary, Olukoya, Ayodeji
Publicado 2022

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer

por Olukoya, Ayodeji O, Stires, Hillary, Bahnassy, Shaymaa, Persaud, Sonali, Guerra, Yanira, Ranjit, Suman, Ma, Shihong, Cruz, M Idalia, Benitez, Carlos, Rozeboom, Aaron M, Ceuleers, Hannah, Berry, Deborah L, Jacobsen, Britta M, Raj, Ganesh V, Riggins, Rebecca B
Publicado 2023